Chronic cough, defined as a cough persisting for more than eight weeks, is a common yet perplexing clinical scenario. Despite its prevalence, the etiological understanding and management strategies often pose challenges to clinicians. This article aims to offer a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Chronic cough can be attributed to a myriad of causes, including but not limited to asthma, gastroesophageal reflux disease (GERD), and postnasal drip syndrome. A thorough patient history and physical examination are paramount in identifying potential triggers. The role of diagnostic tests such as spirometry, chest radiography, and laryngoscopy cannot be understated.
Treatment should be tailored according to the underlying cause. For instance, inhaled corticosteroids are beneficial in cough-variant asthma, while proton pump inhibitors are recommended for GERD-associated cough. However, in cases of unexplained chronic cough, a stepwise therapeutic approach may be employed. This includes empirical treatment trials and specialized investigations if necessary.
Emerging therapies such as neuromodulators and speech therapy have shown promise in the management of chronic cough. Neuromodulators like gabapentin and amitriptyline can be considered in refractory cases. Speech therapy, on the other hand, focuses on behavioral strategies to reduce cough severity and frequency.
Chronic cough is a multifactorial condition requiring a comprehensive approach for effective diagnosis and management. Clinicians should be adept at navigating through the potential etiologies and tailoring treatment accordingly. The incorporation of emerging therapies into the treatment algorithm may offer additional benefits. Continued research and clinical trials are necessary to further elucidate the pathophysiology of chronic cough and improve patient outcomes.
1.
Can Prior Authorization Be Better With Artificial Intelligence?
2.
How a California Oncologist Making $850k Spends Money
3.
DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
1.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
2.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
3.
Erythropoiesis Modulation in Chronic Anemia Management
4.
Comprehensive Concepts in Oncology in Clinical Decision-Making
5.
Precision Cancer Risk Mitigation Strategies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
Managing Supportive Care During Platelet Recovery
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation